These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20800406)

  • 1. Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product.
    Liu C; Dong S; Xu XJ; Yin Y; Shriver Z; Capila I; Myette J; Venkataraman G
    J Pharm Biomed Anal; 2011 Jan; 54(1):27-36. PubMed ID: 20800406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact protein analysis in the biopharmaceutical field.
    Staub A; Guillarme D; Schappler J; Veuthey JL; Rudaz S
    J Pharm Biomed Anal; 2011 Jun; 55(4):810-22. PubMed ID: 21334842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of intact human follicle-stimulating hormone preparations by reversed-phase high-performance liquid chromatography.
    Loureiro RF; de Oliveira JE; Torjesen PA; Bartolini P; Ribela MT
    J Chromatogr A; 2006 Dec; 1136(1):10-8. PubMed ID: 17049544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary investigation of glycosylated proteins by capillary electrophoresis and capillary electrophoresis/mass spectrometry using electrospray ionization and by matrix-assisted laser desorption ionization/time-to-flight mass spectrometry.
    Bonfichi R; Sottani C; Colombo L; Coutant JE; Riva E; Zanette D
    Rapid Commun Mass Spectrom; 1995; Spec No():S95-106. PubMed ID: 8829487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct analysis of pharmaceutical tablet formulations using Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry Imaging.
    Earnshaw CJ; Carolan VA; Richards DS; Clench MR
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1665-72. PubMed ID: 20486264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoproteomics of N-glycosylation by in-gel deglycosylation and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry mapping: application to congenital disorders of glycosylation.
    Sagi D; Kienz P; Denecke J; Marquardt T; Peter-Katalinić J
    Proteomics; 2005 Jul; 5(10):2689-701. PubMed ID: 15912511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials.
    Gavin PF; Olsen BA; Wirth DD; Lorenz KT
    J Pharm Biomed Anal; 2006 Jun; 41(4):1251-9. PubMed ID: 16621411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400.
    Kochling JD; Miao H; Young CR; Looker AR; Shannon M; Montgomery ER
    J Pharm Biomed Anal; 2007 Apr; 43(5):1638-46. PubMed ID: 17224256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of mixed-mode ion-exchange solid phase extraction to characterize pharmaceutical drug degradation.
    Landis MS
    J Pharm Biomed Anal; 2007 Sep; 44(5):1029-39. PubMed ID: 17553650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experimental comparison of electrospray ion-trap and matrix-assisted laser desorption/ionization post-source decay mass spectra for the characterization of small drug molecules.
    LeRiche T; Osterodt J; Volmer DA
    Rapid Commun Mass Spectrom; 2001; 15(8):608-14. PubMed ID: 11312511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of new analytical technology to the production of a "well-characterized biological".
    Apffel A; Chakel J; Udiavar S; Swedberg S; Hancock WS; Souders C; Pungor E
    Dev Biol Stand; 1998; 96():11-25. PubMed ID: 9890511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with internal calibration.
    Belgacem O; Buchacher A; Pock K; Josic D; Sutton C; Rizzi A; Allmaier G
    J Mass Spectrom; 2002 Nov; 37(11):1118-30. PubMed ID: 12447888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the analysis of steroid hormone drugs in pharmaceuticals and environmental samples (2004-2010).
    Görög S
    J Pharm Biomed Anal; 2011 Jun; 55(4):728-43. PubMed ID: 21131155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency.
    Gervais A; Hammel YA; Pelloux S; Lepage P; Baer G; Carte N; Sorokine O; Strub JM; Koerner R; Leize E; Van Dorsselaer A
    Glycobiology; 2003 Mar; 13(3):179-89. PubMed ID: 12626416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of high resolution LC-MSn analysis in conjunction with mechanism-based stress studies: identification of asarinin, an impurity from sesame oil in an animal health product.
    Wang X; Peng Y; Li M; Rustum AM
    J Pharm Biomed Anal; 2009 Dec; 50(5):1015-21. PubMed ID: 19631486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for identification of leachables in packaged pharmaceutical liquid formulations.
    Pan C; Harmon F; Toscano K; Liu F; Vivilecchia R
    J Pharm Biomed Anal; 2008 Feb; 46(3):520-7. PubMed ID: 18180126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperexpression and purification of biologically active human luteinizing hormone and human chorionic gonadotropin using the methylotropic yeast, Pichia pastoris.
    Gadkari R; Deshpande R; Dighe RR
    Protein Expr Purif; 2003 Dec; 32(2):175-84. PubMed ID: 14965762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.